Sudha Parasuraman
Technik-/Wissenschafts-/F&E-Leiter bei Ribon Therapeutics, Inc.
Profil
Sudha Parasuraman is an Independent Director at Terray Therapeutics, Inc. and the Chief Medical Officer at Ribon Therapeutics, Inc. She holds a doctorate degree from the University of Madras.
Aktive Positionen von Sudha Parasuraman
| Unternehmen | Position | Beginn |
|---|---|---|
Terray Therapeutics, Inc.
 Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Terray Therapeutics, Inc. operates as a biotechnology company. It utilizes a novel spatially encoded screening and optimization platform (tArray) to develop treatments for historically intractable causes of human disease .The company was founded by Jacob Berlin, Gregory Copeland and Eli Berlin and is headquartered in Pasadena, CA. | Direktor/Vorstandsmitglied | 16.05.2023 |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Sudha Parasuraman
| University of Madras | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Terray Therapeutics, Inc.
Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Terray Therapeutics, Inc. operates as a biotechnology company. It utilizes a novel spatially encoded screening and optimization platform (tArray) to develop treatments for historically intractable causes of human disease .The company was founded by Jacob Berlin, Gregory Copeland and Eli Berlin and is headquartered in Pasadena, CA. | Commercial Services |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Health Technology |